Figure 4.
Univariate analysis for baseline, clinical, and genomic features in biTET2ivs wild-type. Univariate analysis showing the significant results for baseline (older age, lower risk, MDS, MDS/MPN, CMML, and normal cytogenetics), clinical (leukopenia, neutropenia, monocytosis, pancytopenia, BM blasts, BM hypercellularity, and myeloid dysplasia), and genomic (KRAS/NRASMT, SRSF2MT, and TP53MT) features in biTET2i vs TET2WT.

Univariate analysis for baseline, clinical, and genomic features in biTET2ivs wild-type. Univariate analysis showing the significant results for baseline (older age, lower risk, MDS, MDS/MPN, CMML, and normal cytogenetics), clinical (leukopenia, neutropenia, monocytosis, pancytopenia, BM blasts, BM hypercellularity, and myeloid dysplasia), and genomic (KRAS/NRASMT, SRSF2MT, and TP53MT) features in biTET2i vs TET2WT.

Close Modal

or Create an Account

Close Modal
Close Modal